Better survival and prognosis in SCLC survivors after combined second primary malignancies: A SEER database-based study

With recent advances in treatment modalities, the survival time for patients with small cell lung cancer (SCLC) has increased, along with the likelihood of recurrence of a second primary tumor. However, patient treatment options and prognosis remain uncertain. This research evaluated the survival ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Silin, Hu, Sheng, Huang, Shengfei, Su, Lang, Guo, Qiang, Wu, Bo, Ye, Jiayue, Zhang, Deyuan, Zhang, Yang, Zhang, Wenxiong, Wei, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907942/
https://www.ncbi.nlm.nih.gov/pubmed/36820587
http://dx.doi.org/10.1097/MD.0000000000032772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907942/
https://www.ncbi.nlm.nih.gov/pubmed/36820587
http://dx.doi.org/10.1097/MD.0000000000032772

Ejemplares similares